tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Walsh, 82 are a BUY (83.67%), 14 are a HOLD (14.29%), 2 are a SELL (2.04%).
Analyst Adam Walsh, currently employed at ROTH, carries an average stock price target met ratio of 60.92% that have a potential upside of 37.51% achieved within 361 days. Previously, Adam Walsh worked at ROTH MKM.
Adam Walsh’s has documented 187 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 15-Sep-2026.
Analyst best performing recommendations are on VRTX (VERTEX PHARMACEUTICALS).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) at 7/18/2017. The price target of $154 was fulfilled within 1 day with a profit of $21.84 (16.53%) receiving and performance score of 165.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$17
3 years 9 months 9 days ago
(20-Jan-2023)
0/1 (0%)
$10.12 (147.09%)
Buy
$25
3 years 9 months 10 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Hold Since 19-Jan-2023
$25
3 years 9 months 10 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Buy Since 10-Aug-2020
$14
3 years 9 months 11 days ago
(19-Jan-2023)
0/2 (0%)
$8.11 (137.69%)
Buy Since 04-Nov-2020
$10
3 years 9 months 11 days ago
(19-Jan-2023)
0/3 (0%)
$6 (150.00%)
Which stock is Adam Walsh most bullish on?
Which stock is Adam Walsh most reserved on?
What Year was the first public recommendation made by Adam Walsh?
